Salix Pharmaceuticals, Ltd. Says Watson Pharmaceuticals, Inc. to Sell Generic Anti-Inflammatory Drug; Salix Shares Sink

Dec 28 (Reuters) - Salix Pharmaceuticals Ltd (SLXP.O: Quote, Profile, Research) said Watson Pharmaceuticals Inc (WPI.N: Quote, Profile, Research) will market an authorized generic of its anti-inflammatory drug, Colazal.

Back to news